Navigation Links
Sirolimus therapy alleviates symptoms of lung disease LAM
Date:3/16/2011

WHAT: Sirolimus, a drug currently used to help prevent transplant rejection, can improve lung function and quality of life in individuals living with the lung disease lymphangioleiomyomatosis (LAM), according to the results of a new study sponsored and conducted in part by the National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health.

"Efficacy and Safety of Sirolimus in Lymphangioleiomyomatosis," will be published online March 16 in the New England Journal of Medicine.

LAM is a rare and progressive lung disease in which cancer-like cells infiltrate the lung, leading to shortness of breath, coughing, chest pain, and in many cases eventual respiratory failure. LAM affects almost exclusively women, primarily of child-bearing age. Though only around 1,000 women in the U.S. have diagnosed LAM, there may be many more as the disease is not well-diagnosed.

This international study, led by the University of Cincinnati, recruited 89 LAM patients to test sirolimus, a drug that can suppress rapid cell growth by blocking an overactive protein called mTOR. Sirolimus is already used as an immune suppressant for organ transplants and is also being tested as a cancer drug. mTOR is also highly active in the invading cells that cause LAM.

The participants took daily oral doses of sirolimus or placebo over 12 months and had their lung function measured at regular intervals. The primary measurement was forced expiratory volume (FEV1), or the volume of air that can be forced out in the first second after taking a deep breath. The sirolimus group displayed stable FEV1 levels over the 12-month treatment period, compared to a roughly 12% decline in the placebo group. The sirolimus group also showed other clinical improvements, and reported a greater ability to carry out day-to-day functions and a better quality of life.

Following the treatment period, the study participants underwent 12-mo
'/>"/>

Contact: NHLBI Communications Office
NHLBI_news@nhlbi.nih.gov
301-496-4236
NIH/National Heart, Lung and Blood Institute
Source:Eurekalert

Page: 1 2

Related medicine news :

1. Research study explores gene therapy treatment to reduce symptoms of Parkinsons disease
2. University Hospitals Case Medical Center testing innovative heat therapy for premature ejaculation
3. Ohio State study: Targeted ovarian cancer therapy not cost-effective
4. Stroke patients benefit from family involvement in exercise therapy
5. Extra Tests Not a Deterrent to Experimental Cancer Therapy
6. Gene Therapy Against HIV Not a Proven Cure, Experts Say
7. WSU researcher creates patented personalized therapy that causes cancer cells to kill themselves
8. BUSM study shows chemoradiotherapy prior to surgery improves survival
9. Fish oil fights weight loss due to chemotherapy
10. Lack of health insurance limits hepatitis C patients access to latest antiviral therapy
11. Protective strategy shields primate ovaries from radiation-therapy-induced damage
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/27/2015)... 2015 Royal River Natural Foods, a locally-owned ... study that found adults who got the most magnesium were ... compared to those who got the least magnesium, with the ... The report is part of the March 2015 issue of ... Natural Foods publishes free each month for the Freeport community ...
(Date:2/27/2015)... Adding to its rich history ... Advertising & Marketing has added Sedation Systems of ... patented NITROUSEAL® N20 closed mask and breathing circuit ... , Sedation Systems, http://www.sedationsystems.com is dedicated ... level, though it focuses primarily on pediatric patients. ...
(Date:2/27/2015)... (PRWEB) February 27, 2015 FACE ... therapies, has announced a unique combination to take ... neck. Ultherapy Décolletage is a new treatment introduced ... noninvasive procedure specifically indicated to improve lines and ... for any person who suffers from the stubborn ...
(Date:2/27/2015)... 2015 The Nashville periodontist ... scholarship for rising freshmen undergraduate students. , The Advanced ... specializing in many periodontal procedures such as dental ... gum disease . In honor of their 25th anniversary, ... eligible rising freshmen undergraduate students. , Students interested ...
(Date:2/27/2015)... Ford, Pennsylvania (PRWEB) February 27, 2015 ... the Spring Breast Augmentation Special at his Chadds Ford, ... 13 through May 1, 2015, and will be priced ... to the latest silicone implants, it will include more ... price and $250 worth of free Dysport. , Space ...
Breaking Medicine News(10 mins):Health News:New Study Finds Magnesium May Slow Progress of Diabetes, Retailer Reports 2Health News:Benedict Advertising & Marketing Signs Sedation Systems 2Health News:Face Skincare Announces New Combination Therapy 2Health News:Nashville Periodontist Office AIOH Announces 2015 Scholarship 2Health News:Dr. Christopher Saunders Announces Spring Breast Augmentation Special at $3,950 2Health News:Dr. Christopher Saunders Announces Spring Breast Augmentation Special at $3,950 3
... nasal spray to quash allergy symptoms may work better ... an "as-needed'', rather than daily basis, the nasal spray ... sneezing and congestion more effectively than the antihistamine loratadine ... fights allergy symptoms by reducing the inflammation that occurs ...
... intravenous magnesium sulfate to standard emergency department migraine ... enhance the effectiveness of treatment.// Dr. Jill Corbo, ... Medicine in the Bronx, New York, note that ... in the treatment of migraine headache and that ...
... to bear an underweight child, but some women may ... susceptibility.// The finding could help medicine better determine the ... they were not recommending at this point that women ... ,"Our data demonstrate that a subgroup of pregnant ...
... that butterbur extract is an effective antihistamine without any ... an active biochemical agent,// otherwise it would not work ... react with other medications. ,It was used ... either butterbur extract tablets or the usually used non-sedating ...
... 40,000 more lives each year worldwide if more people at ... it, doctors said.// An analysis of nearly 300 clinical ... prevent blood clots confirmed that aspirin reduces heart attacks and ... people who could benefit from aspirin and anti-platelet therapy receive ...
... stones, which are often extremely painful to excrete, cost ... lost productivity. While the stones can sometimes be prevented ... the bladder frequently,// medication to reduce the excretion of ... increase cholesterol and can cause bloating and other uncomfortable ...
Cached Medicine News:
(Date:2/27/2015)... 2015 Securities lawyers at Dunnam & ... Ltd. (NASDAQ: SLXP ) in connection with ... investors are encouraged to contact attorney Hamilton Lindley by ... focuses upon the shareholder value of the transaction. Under ... only $158.00 per share in cash. At least one ...
(Date:2/27/2015)... , February 27, 2015 Report ... study showing you trends, R&D progress, and predicted revenues ... heading? What are the commercial prospects for this market ... potential revenues and other trends to 2025, discussing data, ... lets you assess regenerative medicine : cell-based therapies ...
(Date:2/27/2015)...  Organovo Holdings, Inc. (NYSE MKT: ONVO) ("Organovo"), ... 3D bioprinting technology, announced today that Keith ... present live at VirtualInvestorConferences.com on March 5th. ... for this Company update," said Mr. Murphy. "We ... of the exVive3D Liver, Bioprinted Human Tissue, commercialization ...
Breaking Medicine Technology:Translational Regenerative Medicine: Market Prospects 2015-2025 2Translational Regenerative Medicine: Market Prospects 2015-2025 3Translational Regenerative Medicine: Market Prospects 2015-2025 4Translational Regenerative Medicine: Market Prospects 2015-2025 5Translational Regenerative Medicine: Market Prospects 2015-2025 6Translational Regenerative Medicine: Market Prospects 2015-2025 7Translational Regenerative Medicine: Market Prospects 2015-2025 8Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 2Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 3Organovo Holdings, Inc. to Provide Corporate Update and Investor Presentation in a Live, Interactive Webcast on March 5th 4
... The IMMULITE 1000 immunoassay system features ... reliability, robust hardware and excellent assay ... reagents and accommodates onboard dilutions, positive ... , Worldwide, IMMULITE 1000 (and its ...
... The AIA-1800 is the newest and most ... Inc. The AIA-1800 launches with a full ... markers, thyroid, reproductive, cardiac, and anemia assays. ... throughput, bar-coded primary tube sampling, auto dilution, ...
The FastPack system is a state of the art, lab quality immunoassay system designed for rapid results. The FastPack system delivers lab-quality sensitivity at a fraction of the cost of laboratory....
... 250 is a flexible system ... multiple environments small hospitals, ... and satellite locations. The Vitros ... and can be automated or ...
Medicine Products: